Here are direct links to some of the poster presentations and published abstracts regarding Narcolepsy Type 1 from the recent SLEEP 2026 conference exhibit hall.
Disclaimer: This post is for informational purposes only regarding new clinical trials and does not constitute medical advice.
------------
"Effect of treatment with oveporexton, an orexin receptor 2 agonist, on sleep in people with narcolepsy type 1: Phase 3 results"

